We recently met Govind Shrikhande, MD, Shoppers Stop (SSL). Apart from recent IPO listing which has re-rated most retail stocks, we expect retailers like SSL to reap benefits from higher discretionary spends.
Reliance Capital (RCAP) hosted an analyst meet attended by Anil Ambani and management team from across business segments to spell out its growth strategy. The chairman appears firm to wind down major part of non-core business
As against fears of gold loan companies bearing major brunt of demonetisation, Muthoot’s business practices helped it recover swiftly with: AUM growth of 8% y-o-y versus initial expectation of decline; and GNPLs rise restri
According to data from Agricultural and Processed Food Products and Export Development Authority (Apeda), exports in April-December FY17 stood at Rs 76,902 crore, 3.7% lower than same period last year.
Bharat Forge (BHFC) sustained sequential growth in exports for the second quarter in a row led by industrial pick up in US market, which complemented healthy growth in CVs and improving industrial revenues in domestic market.
Glenmark Pharmaceuticals’ (GNP) Q3FY17 was driven by the 180 days exclusivity for gZetia that may have contributed $70 million. However, rest of business was sluggish, with India hit by demonetisation and halt of sales in V
United Spirits (USL) posted superior revenue and EBITDA growth of 2.9% and 9.8% y-o-y, respectively, as impact of demonetisation was lower than our expectation. Overall, volumes dipped 4.3% y-o-y on the 10.6% y-o-y decline in
Dewan Housing Finance’s (DHFL) Q3FY17 PAT, at R2.45 billion (up 32% Year-on-Year), was marginally better than our estimates owing to better NIMs (broadly stable Quarter-on-Quarter versus expectation of decline).
The recent demonetisation move is expected to impact on Q3FY17 performance. We estimate our media universe to report tepid revenue growth of 2.2% y-o-y (15.0% in Q2FY17) and subdued 0.9% y-o-y Ebitda growth (24.1% in Q2FY17).